Canada’s Covid Hot Spot May Look to Sell ‘Stimulus Bonds’
(Bloomberg) -- Montreal should seek permission to run a deficit and consider selling special bonds to help fund its economic recovery from the coronavirus, according to an expert report it commissioned.
“Stimulus bonds” are needed in addition to aid from federal and provincial governments after lockdown measures hurt revenue, especially from public transportation, the report says. Montreal has been reopening its economy slowly after Covid-19 spread inside nursing homes, killing nearly 3,000 people in Canada's second-largest city and making it one of the epicenters of the pandemic in North America.
Local governments in Canada are not allowed to run operating deficits in most cases, though they do issue debt to help fund capital projects. The city of Montreal is rated AA- by S&P Global Ratings and Aa2 by Moody's Investors Service.
The deficit proposal appears “pertinent,” said Mayor Valerie Plante, who said the city is already in the red and waiting for the federal and Quebec governments to follow up on pledges to help the city. The report by economists and other experts says Montreal should ask Quebec to temporary suspend the rules that require it to balance its books.
Read more: Canada's Covid Hot Zone Is Deadlier Than Chicago or L.A.
“When you want to support the economy you need levers, a strong strategy,” Plante said during a press conference. Under current rules and without government support, “I have two options left: tax, cut services, or both.”
The report makes 16 recommendations on how to help the city recover, from easing property taxes for some sectors to helping workers get together and buy companies.
A lobby group for municipal governments has asked for at least C$10 billion ($7.4 billion) in emergency funding to deal with shortfalls in subway and bus fares, user fees and other revenue sources. Prime Minister Justin Trudeau this week offered to give them an advance on billions of dollars of gasoline tax money that is earmarked for cities and towns.
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.